565 related articles for article (PubMed ID: 19725378)
1. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
2. Implementation of human papillomavirus immunization in the developing world.
Kane MA; Serrano B; de Sanjosé S; Wittet S
Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
4. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
6. Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine.
Kane MA
Gynecol Oncol; 2010 May; 117(2 Suppl):S32-5. PubMed ID: 20129654
[TBL] [Abstract][Full Text] [Related]
7. Introduction of human papillomavirus vaccination in Nordic countries.
Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
[TBL] [Abstract][Full Text] [Related]
8. Chapter 15: HPV vaccine use in the developing world.
Kane MA; Sherris J; Coursaget P; Aguado T; Cutts F
Vaccine; 2006 Aug; 24 Suppl 3():S3/132-9. PubMed ID: 16950000
[TBL] [Abstract][Full Text] [Related]
9. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
10. Public health issues related to HPV vaccination.
Hershey JH; Velez LF
J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
13. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
14. Decreasing risk: impact of HPV vaccination on outcomes.
Hymel PA
Am J Manag Care; 2006 Dec; 12(17 Suppl):S473-83. PubMed ID: 17203991
[TBL] [Abstract][Full Text] [Related]
15. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
17. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against human papillomavirus.
BMJ Group
Drug Ther Bull; 2008 Dec; 46(12):89-93. PubMed ID: 19056700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]